Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pathologic laughing as a presenting feature in a patient with neuromyelitis optica.
Comparison of diffusion-weighted imaging and contrast-enhanced T1-weighted imaging on a single baseline MRI for demonstrating dissemination in time in multiple sclerosis.
How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis?
Tiliroside, a dietary glycosidic flavonoid, inhibits TRAF-6/NF-κB/p38-mediated neuroinflammation in activated BV2 microglia.
Epstein-barr virus: the path from association to causality for a ubiquitous human pathogen.
Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms.
Multiple sclerosis: new measures to monitor the disease.
Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
Multiple sclerosis drug fingolimod receives new safety warnings related to cardiovascular risk.
Targeted GAS6 Delivery to the CNS Protects Axons from Damage during Experimental Autoimmune Encephalomyelitis.
Spinal cord tumour misdiagnosed as seropositive neuromyelitis optica spectrum disorder.
Cytokines gene expression in newly diagnosed multiple sclerosis patients.
PANGAEA: Post-authorization Noninterventional German Safety Study of GilEnyA in relapsing-remitting multiple sclerosis (RRMS) patients: A 24-month interim analysis of a German five-year fingolimod registry study.
Nicotinic receptor activation negatively modulates pro-inflammatory cytokine production in multiple sclerosis patients.
The major myelin-resident protein PLP is transported to myelin membranes via a transcytotic mechanism: involvement of sulfatide.
A questionnaire survey comparing the educational priorities of patients and medical students in the management of multiple sclerosis.
Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects.
Cdon, a cell surface protein, mediates oligodendrocyte differentiation and myelination.
Plasma levels of neuron specific enolase quantify the extent of neuronal injury in murine models of ischemic stroke and multiple sclerosis.
Is There Extra Cost of Institutional Care for MS Patients?
Walking and cognition, but not symptoms, correlate with dual task cost of walking in multiple sclerosis.
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis.
[White matter lesions, young age, female - differential diagnosis of multiple sclerosis and juvenile stroke].
Cerebrospinal fluid oligoclonal IgG bands in multiple sclerosis: what does it mean?
Pages
« first
‹ previous
…
433
434
435
436
437
438
439
440
441
…
next ›
last »